Guo Xin, Tan Zongjian
XinGuo, Department of Reproductive Center, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Zongjian Tan, Department of Reproductive Center, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Pak J Med Sci. 2017 Jul-Aug;33(4):1029-1035. doi: 10.12669/pjms.334.13065.
We aimed to evaluate the effectiveness of placebo, oral opioid analgesic (OOA), intravenous opioid analgesic (IOA), non-opioid analgesic (NOA), topical anesthetic (TA) and locally injected anesthetic (LIA) for pain relief duringhysterosalpingography (HSG) using a Bayesian network meta-analysis of data from randomized controlled trials.
PUBMED, EMBASE, and CENTRAL search engines were used to search and identify clinical trials that evaluated interventions for pain relief in HSG. Methodological studies quality was assessed by the Cochrane Collaboration tool for assessing risk of bias.
Sixteen trials involving 1263 participants were included in this study. IOA got excess but not statistically significant lower visual analogue score (VAS) pain score during HSG or more than 30 minutes after HSG compared with the other groups. OOA resulted in excess but not statistically significant higher VAS pain score during HSG compared with the other groups except placebo group. According to SUCRA regarding the lower VAS pain score during HSG, the treatments rank was the following: IOA, TA, NOA, LIA, OOA and placebo; as regard lower VAS pain score at 30 minutes or more after HSG, the treatments rank was the following: IOA, LIA, OOA, TA, NOA and placebo.
This new Bayesian data network meta-analysis from randomized controlled trials demonstrated that IOA resulted in the highest probability to reduce the pain during HSG or at 30 minutes or more after HSG among the six interventions considered.
我们旨在通过对随机对照试验数据进行贝叶斯网络荟萃分析,评估安慰剂、口服阿片类镇痛药(OOA)、静脉注射阿片类镇痛药(IOA)、非阿片类镇痛药(NOA)、局部麻醉剂(TA)和局部注射麻醉剂(LIA)在子宫输卵管造影术(HSG)期间缓解疼痛的有效性。
使用PUBMED、EMBASE和CENTRAL搜索引擎搜索并识别评估HSG疼痛缓解干预措施的临床试验。采用Cochrane协作工具评估偏倚风险来评估方法学研究质量。
本研究纳入了16项试验,涉及1263名参与者。与其他组相比,IOA在HSG期间或HSG后30分钟以上的视觉模拟评分(VAS)疼痛评分更低,但差异无统计学意义。与除安慰剂组外的其他组相比,OOA在HSG期间导致的VAS疼痛评分更高,但差异无统计学意义。根据HSG期间较低VAS疼痛评分的累积排序曲线下面积(SUCRA),治疗排名如下:IOA、TA、NOA、LIA、OOA和安慰剂;对于HSG后30分钟或更长时间较低的VAS疼痛评分,治疗排名如下:IOA、LIA、OOA、TA、NOA和安慰剂。
这项来自随机对照试验的新贝叶斯数据网络荟萃分析表明,在所考虑的六种干预措施中,IOA在HSG期间或HSG后30分钟或更长时间减轻疼痛的可能性最高。